Targeted metabolomic analysis of serum amino acids in heart failure patients

Chunjing Yang,Zhengyuan Shi,Li Bao,Xiqiao Xv,Dechun Jiang,Longtai You

DOI: https://doi.org/10.1007/s00726-024-03385-7

IF: 3.7891

2024-03-15

Amino Acids

Abstract:Heart failure (HF) has been recognized as a global epidemic with high rates of morbidity, hospitalization, and mortality. The role of amino acids, which provide the body with energy, in the development of HF is still unclear. The aim of this study was to explore changes in serum amino acids in patients with HF and identify potential biomarkers. First, the serum amino acid metabolism profiles of 44 patients with HF and 30 healthy controls (Con) were quantitatively measured. Then, candidate markers were identified through the utilization of T test, multivariate statistical analysis, and receiver operating characteristic (ROC) curve analysis. The results found that there were 11 amino acid levels that were significantly different between patients with HF and Con. Based on ROC curve analysis, the biomarkers of eight amino acids (Glutamic acid, Taurine, l -aspartic acid, l -ornithine, Ethanolamine, l -Serine, l -Sarcosine, and Cysteine) showed high sensitivity and specificity (AUC > 0.90), and binary logistic regression analysis was used in MetaboAnalyst 5.0. Among the amino acids examined, six exhibited notable alterations in accordance with the severity of HF. In conclusion, this study cannot only provide clinicians with an objective diagnostic approach for the early identification of HF, but also enhances comprehension of the underlying mechanisms involved in the pathogenesis of HF.

biochemistry & molecular biology

What problem does this paper attempt to address?

### What problems does this paper attempt to solve?

This paper aims to explore the changes in amino acid metabolism in the serum of patients with heart failure (HF) and identify potential biomarkers. Specifically, the study attempts to solve the following key problems:

1. **Changes in amino acid metabolism in heart failure**:
- Heart failure is a global epidemic with a high incidence, hospitalization rate, and mortality rate. Although amino acids play an important role in providing energy for the body, their role in the development of heart failure is not clear.
- The study quantitatively measured the serum amino acid metabolism profiles of 44 heart failure patients and 30 healthy controls to understand whether the amino acid levels in these patients had changed significantly.

2. **Identification of potential biomarkers**:
- The study used methods such as t - test, multivariate statistical analysis, and receiver operating characteristic (ROC) analysis to identify 11 amino acids with significant differences in levels between heart failure patients and healthy controls.
- Among them, 8 amino acids (glutamic acid, taurine, L - aspartic acid, L - ornithine, ethanolamine, L - serine, L - sarcosine, and cysteine) showed high sensitivity and specificity (AUC > 0.90), indicating that they may serve as potential biomarkers for heart failure.

3. **Early diagnosis and understanding of pathological mechanisms**:
- The study not only provides clinicians with an objective diagnostic method, which is helpful for the early identification of heart failure, but also enhances the understanding of the pathogenesis of heart failure.
- In particular, 6 amino acids (taurine, L - serine, ethanolamine, aspartic acid, glutamic acid, and cysteine) showed significant changes with different severities of heart failure, suggesting that changes in amino acid metabolism may be related to the severity of heart failure.

### Conclusion
Through targeted metabolomics analysis of amino acid levels in the serum of heart failure patients, the study revealed significant changes in 11 amino acids and further verified that 8 of them are closely related to the disease state. This finding expands our understanding of the pathophysiological mechanisms of heart failure and provides potential biomarkers for future early detection and treatment.

### Related formulas
- **Area under the ROC curve (AUC)**: It is used to evaluate the accuracy of a diagnostic test, and the formula is:
\[
AUC=\int_{0}^{1} TPR(FPR) \, dFPR
\]
where \( TPR \) is the true positive rate, and \( FPR \) is the false positive rate.

- **VIP score (Variable Importance in Projection)**: It is used to evaluate the importance of each variable in the model, and the formula is:
\[
VIP_j = \sqrt{\frac{p \sum_{a = 1}^{A} w_{aj}^2 t_a^T t_a}{\sum_{k = 1}^{p} \sum_{a = 1}^{A} w_{ak}^2 t_a^T t_a}}
\]
where \( p \) is the number of variables, \( A \) is the number of principal components, \( w_{aj} \) is the weight of the \( j \) - th variable in the \( a \) - th principal component, and \( t_a \) is the score vector of the \( a \) - th principal component.

Through these analyses, the study provides new perspectives and tools for the early diagnosis and treatment of heart failure.